| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87e0796351f86d2a548ba02b85acc233 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2020-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca50922b871ce4b368c84c52713091e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53b344c88725c3d3078c923ac34c9dda |
| publicationDate |
2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020229660-A1 |
| titleOfInvention |
Lymphotoxin alpha for use in therapy of myeloid leukemia |
| abstract |
The present invention relates to a polypeptide for use in the treatment of myeloid diseases or myeloid neoplasms, a pharmaceutical composition comprising such a polypeptide for use in the treatment of myeloid diseases or myeloid neoplasms and a kit comprising such a polypeptide for use in the treatment of myeloid diseases or myeloid neoplasms. |
| priorityDate |
2019-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |